Literature DB >> 16286551

Postinfectious myeloradiculoneuropathy with cranial nerve involvements associated with human herpesvirus 7 infection.

Takateru Mihara1, Tatsuro Mutoh, Tetsusi Yoshikawa, Shigeaki Yano, Yoshizo Asano, Hiroko Yamamoto.   

Abstract

BACKGROUND: Infection with human herpesvirus 7 (HHV-7) generally results in a febrile illness with accompanying exanthema subitum.
OBJECTIVES: To ascertain and describe the role of HHV-7 in a case of acute myeloradiculoneuropathy. PATIENT: A previously healthy young man with complaints of motor weakness, dysphasia, and nasal voice.
METHODS: Serological examinations were performed with the patient's serum. We also examined virus genome DNA in cerebrospinal fluid by regular and real-time polymerase chain reaction. Moreover, we checked the antiganglioside antibody level in the patient's serum samples by the immunoblot analysis.
RESULTS: Serological studies revealed significant change in titers of antibodies against cytomegalovirus, Epstein-Barr virus, and HHV-7, but only HHV-7 genome was detected in the cerebrospinal fluid, with its disappearance after therapy. No antiganglioside antibody was detected in the patient's serum.
CONCLUSION: The unique clinical picture of the present patient might be closely related to the reactivation of HHV-7 in the nervous system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16286551     DOI: 10.1001/archneur.62.11.1755

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  2 in total

1.  Detection of human herpesviruses in cerebrospinal fluids collected from patients suspected of neuroinfectious diseases.

Authors:  Soichiro Ishimaru; Yoshiki Kawamura; Hiroki Miura; Sayuri Shima; Akihiro Ueda; Hirohisa Watanabe; Tatsuro Mutoh; Tetsushi Yoshikawa
Journal:  J Neurovirol       Date:  2021-12-30       Impact factor: 2.643

2.  Encephalitis associated with human herpesvirus-7 infection in an immunocompetent adult.

Authors:  Mónica Parra; Adoración Alcala; Cristina Amoros; Anna Baeza; Antonio Galiana; David Tarragó; Miguel Ángel García-Quesada; Victoria Sánchez-Hellín
Journal:  Virol J       Date:  2017-05-25       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.